| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |